Jacob J. Mandel
Expertise in
16
conditions

Dr. Jacob J. Mandel

Neurology | Oncology | Neurosurgery
1502 Taub Loop, 
Houston, TX 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
16
conditions
1502 Taub Loop, 
Houston, TX 

Overview

Jacob Mandel, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Jacob Mandel specializes in Neurology (Brain and Spine) and works at BCM Neurology. To make an appointment, please call (713) 798-2273. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted.

Dr. Mandel is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

Dr. Mandel is board certified in Neurology From The American Board Of Psychiatry And Neurology, Neuro-Oncology From The American Board Of Psychiatry And Neurology, American Academy Of Neurology, Society Of Neuro-Oncology, American Society Of Clinical Oncology. He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 3 clinical trials. Dr. Mandel is currently accepting new patients.

Specialties

Neurology
Oncology
Neurosurgery

Licenses

Psychiatry & Neurology in TX

Board Certifications

Neurology From The American Board Of Psychiatry And Neurology, Neuro-Oncology From The American Board Of Psychiatry And Neurology, American Academy Of Neurology, Society Of Neuro-Oncology, American Society Of Clinical Oncology

Hospital Affiliations

Baylor St Lukes Medical Center
Harris Health
Baylor St. Luke's Medical Center - Houston, TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

BAYLOR COLLEGE OF MEDICINE
1502 Taub Loop, Houston, TX 77030
Other Locations
BAYLOR COLLEGE OF MEDICINE
6770 Bertner Ave, Suite C 350, Houston, TX 77030
BAYLOR COLLEGE OF MEDICINE
2525 A Holly Hall St, Unit 3c, Houston, TX 77054
BAYLOR COLLEGE OF MEDICINE
7200 Cambridge St, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
An Open-Label, Multi-Center Trial of INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With REGN2810 in Subjects With Newly-Diagnosed Glioblastoma (GBM)
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2026
Intervention Type: Biological, Drug, Radiation
Study Drugs: INO-5401, INO-9012, Cemiplimab, Temozolomide
Study Phase: Phase 1/Phase 2
Phase 1 and Pharmacology Study of Oral 5-Iodo-2-Pyrimidinone-2-Deoxyribose (IPdR) as a Prodrug for IUdR-Mediated Tumor Radiosensitization in Brain Metastases
Phase 1 and Pharmacology Study of Oral 5-Iodo-2-Pyrimidinone-2-Deoxyribose (IPdR) as a Prodrug for IUdR-Mediated Tumor Radiosensitization in Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2026
Intervention Type: Other, Drug, Radiation
Study Phase: Phase 1
View 2 Less Clinical Trials

69 Total Publications

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Similar Doctors
Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required

Office

1400 Holcombe Blvd Unit 428, 
Houston, TX 
 (0.6 miles away)
713-792-2813
Languages Spoken:
English
See accepted insurances

Hagop Kantarjian is an Oncologist practicing medicine in Houston, Texas. Dr. Kantarjian is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Splenectomy.

Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
 (0.3 miles away)
713-792-8850
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Neeta Somaiah is an Oncologist practicing medicine in Houston, Texas. Dr. Somaiah is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Hepato-Pancreato-Biliary Surgery.

Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required

Baylor College Of Medicine Medical Center

7200 Cambridge St., Ste 9A, 
Houston, TX 
 (0.8 miles away)
713-798-2273
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Jankovic is a Neurologist practicing medicine in Houston, Texas. Dr. Jankovic is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Benign Essential Blepharospasm, Drug Induced Dyskinesia, Movement Disorders, Torticollis, and Deep Brain Stimulation. Dr. Jankovic is currently accepting new patients.

Frequently Asked Questions about Dr. Jacob J. Mandel

How do I make an appointment with Dr. Jacob J. Mandel?

You can book an appointment with Dr. Jacob J. Mandel by calling their office at 713-873-4900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jacob J. Mandel a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jacob J. Mandel is classified as an Elite expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jacob J. Mandel specialize in?

While Dr. Jacob J. Mandel is a Neurology, they have specific expertise in Astrocytoma, Glioblastoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Jacob J. Mandel participate in research or clinical trials?

Yes. Dr. Jacob J. Mandel has published 69 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. Jacob J. Mandel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jacob J. Mandel accept my insurance?

Dr. Jacob J. Mandel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-873-4900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mandel's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile